[Can thymostimulin influence the course of malignant subacute hepatitis?].
Tripi
S
S
Migneco
G
G
Mascarella
A
A
Di Marco
P
P
La Cascia
C
C
Citarrella
P
P
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D001706:Biopsy; D005260:Female; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D006525:Hepatitis, Viral, Human / Q000188:drug therapy*; D006801:Humans; D008099:Liver / Q000473:pathology; D013949:Thymus Extracts / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D013949:Thymus Extracts; C031407:thymostimulin
Può la timostimolina influenzare il decorso dell'epatite sub-acuta maligna?